medigraphic.com
ISSN 2225-4676 (Electronic)

2013, Number 2

<< Back Next >>

Rev Cubana Neurol Neurocir 2013; 3 (2)

Characteristics of intracraneal metastasis in 14 321 autopsy carry out in “Dr. Luis Díaz Soto” Hospital, La Habana (1962-2011)

Caballero GJ, Hurtado de Mendoza AJ, Cruz GO, Montero GTJ, Felipe MA

Language: Spanish
References: 27
Page: 132-138
PDF size: 298.38 Kb.


ABSTRACT

Objective: To determine the demographic and anatomo–pathological characteristic of the brain metastases, as well as the frequency of neurological death.
Methods: It was carried out a traverse retrospective descriptive observational study. The entirety of studies postmortem carried out to patient of 15 years were processed and more in the Dr. Luis Diaz Soto’s Hospital in the period understood among December from 1962 to December of 2011, contained in the database of Autopsies created by the SARCAP.
Results: The brain metastases corresponded to 2.4 % of the total of autopsies and 8.9 % of the total of deceased’s with systemic cancer. The age average 55.8 years. It prevailed in masculine sex (1.4:1). The lung prevailed as primary organ. The more frequent was supratentorial (70 %) and cortico-subcortical (81.9 %) localization. The neurological death presented a frequency of 36.1 %.
Conclusions: The brain metastases had a low frequency. The demographic and anatomo-pathological characteristics corresponded with previous studies. It was a low proportion of metastases of unknown origin. The frequency of neurological death went similar to that of the clinical series.


REFERENCES

  1. Nayak L, Lee EQ, Wen PY. Epidemiology of Brain Metastases. Curr Oncol Rep. 2012;14(1):48-54.

  2. American Cancer Society. Cancer Facts & Figures 2012. Atlanta: American Cancer Society; 2012.

  3. Brem SS, Bierman PJ, Brem H, Butowski N, Chamberlain MC, Chiocca EA, et al. NCCN Clinical Practice Guidelines in Oncology for Central Nervous System Cancers. JNCCN. 2011;9(4):352-400.

  4. Central Nervous System Cancers. [página principal de un sitio Web] Washington: National Comprehensive Cancer Network; c2001-13 [Citado 14.01.2013]. Disponible en: http://www.nccn.org/about/news/ebulletin/2010-07- 26/prostate_therapy.asp

  5. Preusser M, Capper D, Ilhan-Mutlu AI,BerghoffAS, Birner P, Bartsch R et al. Brain metastases: pathobiology and emerging targeted therapies. Acta Neuropathol. 2012;123:205–22.

  6. Santatarelli JC, Sarkissian V, Hou LC. Veeravagu A, Tse V. Molecular events of brain metastasis. Neurosurg Focus. 2007;22(3):1-5.

  7. Caballero García J, Felipe Morán A, Toledo Valdés C, Pérez La O P, Morales Pérez I. Consideraciones anatomopatológicas y demográficas de la metástasis intracraneal. Rev Cubana Neurol Neurocir. 2012;2(1):23– 7.

  8. Soffietti R, Cornu P, Delattre JY, Grant R, Graus F, Grisold W, et al. Brain metastases. En: Gilhus NE, Barnes MP, Brainin M (Ed). European Handbook of Neurological Management. 2nd ed. Oxford: Blackwell Publishing Ltd.; 2011. p. 437-45.

  9. Sloan AE, Nock CJ, Einstein DB. Diagnosis and treatment of melanoma brain metastasis: a literature review. Cancer Control. 2009;16:248–55.

  10. Meyners T, Heisterkamp C, Kueter JD, et al. Prognostic factors for outcomes after whole-brain irradiation of brain metastases from relatively radioresistant tumors: a retrospective analysis. BMC Cancer. 2010;10:582.

  11. Sajama C, Lorenzoni J, Tagle P. Diagnóstico y tratamiento de las metástasis intracraneales. Rev Med Chile. 2008;136:1321-6.

  12. Yang H, Kano H, Lunsford L, Dade N, Ajay M, Flickinger J et al. What Factors Predict the Response of Larger Brain Metastases to Radiosurgery? Neurosurgery. 2011;68(3):682-90.

  13. Grossman R, Mukherjee D, Chang DC, Purtell M, Lim M, Brem H, et al. Predictors of inpatient death and complications among postoperative elderly patients with metastatic brain tumors. Ann Surg Oncol. 2011;18:521–8.

  14. Roos D. What is the randomised evidence for surgery and stereotactic radiosurgery for patients with solitary (or few) brain metastases?j Int J Evid Based Health. 2011;9:61–6.

  15. Elliot R, Rush S, Amr M, Mentha N, Spriet J, Ashwatha A, Bernadine D. Local Control of Newly Diagnosed and Distally Recurrent, Low-Volume Brain Metastases With Fixed-Dose (20 Gy) Gamma Knife Radiosurgery. Neurosurgery. 2011;68(4):921-31.

  16. Davies MA, Liu P, Mc Intyre S, Kim KB, Papadopoulos N, Hwu WJ et al. Prognostic Factors for Survival in Melanoma Patients With Brain Metastases. Cancer. 2011;117:1687– 96.

  17. Nieder C, Spanne O, Mehta MP, Grosu AL, Geinitz H. Presentation, Patterns of Care, and Survival in Patients With Brain Metastases What Has Changed in the Last 20 Years? Cancer. 2011;117: 2505–12.

  18. Hatiboglu M, Chang EL, Suki D, Sawaya R, Wildrick D, Weinberg JS. Outcomes and Prognostic Factors for Patients with Brainstem Metastases Undergoing Stereotactic Radiosurgery. Neurosurgery. 2011;69(4):796- 806.

  19. Hurtado de Mendoza Amat J, Álvarez Santana R, Jiménez López A, Fernández Pérez LG. El SARCAP. Sistema Automatizado de Registro y Control de Anatomía Patológica. Rev Cubana Med Milit. 1995; 24:123-30.

  20. Calderón Alfaro F, Zamora Estrada E, Acosta Alvarado F. Neoplasias metastásicas al sistema nervioso central: revisión de diez años (1987-1997) 3.412 casos de autopsia en el Hospital México. Neuroeje. 2000;14(1):31-3.

  21. Salvati M, Frati A, D' Elia A, Pescatori L, Piccirilli M, Pietrantonio, et al. Single brain metastases from melanoma: remarks on a series of 84 patients. Neurosurg Rev. 2012;35: 211-8.

  22. Paget S. The distribution of secondary growths in cancer of the breast. Lancet. 1889;1:571–3.

  23. Delantree JY, Krol G, Thaler HT, Posner JB. Distribution of brain metastases. Arch Neurol. 1988;45:741-4.

  24. Ammirati M, Cobbs CS, Linskey MA, Paleologos NA, Ryken TC, Burri SH, et al. The role of retreatment in the management of recurrent/progressive brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol. 2010;96:85–96.

  25. Rades D, Veninga T, Hornung D, Wittkugel O, Schild SE, Gliemroth J. Single Brain Metastasis: Whole-Brain Irradiation Plus Either Radiosurgery or Neurosurgical Resection Cancer. 2012;118(4):1138-44.

  26. Tsao M, Xu, W, Sahgal A. A Meta-Analysis Evaluating Stereotactic Radiosurgery, Whole-Brain Radiotherapy, or Both for Patients Presenting with a Limited Number of Brain Metastases. Cancer. 2011;118 (9):2486-93.

  27. Kocher M, Soffietti R, Abacioglu U, et al. Adjuvant whole brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol. 2011;29:134-41.




2020     |     www.medigraphic.com